How have LFMD and NRXP total returns compared?

Over the past 5 years, LFMD delivered -14.66% and NRXP delivered -49.61% annualized total return. Past performance doesn't predict future results.

LifeMD, Inc. (LFMD) vs NRx Pharmaceuticals, Inc. (NRXP)

A side-by-side comparison of LifeMD, Inc. and NRx Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

LFMD

LifeMD, Inc.

$132M

$2.73HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

NRXP

NRx Pharmaceuticals, Inc.

$127M

$2.94HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — LFMD vs NRXP

growth of $100 · dividends reinvested · last 9y

LFMD +36.0% (+3.5%/yr)NRXP -97.0% (-32.3%/yr)LFMD compounded faster over this window

Log scale — wide-divergence pair

LFMD NRXP

LFMD vs NRXP: by the numbers

•LFMD is the larger company ($132M vs $127M market cap).
•Both run net losses; LFMD's is the smaller (-10.40% vs -691.81% net margin).

Metrics side by side

Valuation

Metric	LFMD	NRXP
P/S ratio	0.65	37.50
P/B ratio	16.57	N/A

Profitability

Metric	LFMD	NRXP
Gross margin	85.91%	58.78%
Operating margin	-9.35%	-1324.41%
Net margin	-10.40%	-691.81%
ROE	-266.86%	N/A
ROIC	-143.97%	N/A

Growth (annualized)

Metric	LFMD	NRXP
Revenue CAGR (5Y)	26.00%	N/A
Total return CAGR (5Y)	-14.66%	-49.61%

Frequently asked

How have LFMD and NRXP total returns compared?: Over the past 5 years, LFMD delivered -14.66% and NRXP delivered -49.61% annualized total return. Past performance doesn't predict future results.

Go deeper

Full LFMD analysis Full NRXP analysis Interactive comparison tool

Dig into the metrics

LifeMD ROE NRx Pharmaceuticals ROE LifeMD operating margin NRx Pharmaceuticals operating margin LifeMD revenue growth NRx Pharmaceuticals revenue growth LifeMD free cash flow NRx Pharmaceuticals free cash flow

LifeMD & NRx Pharmaceuticals appear in these rankings

Fastest Revenue Growth Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.